What's Happening?
Panome Bio, a multi-omics contract research organization, has partnered with Audubon Bioscience to provide comprehensive FFPE biospecimen and metabolomics solutions for cancer researchers. Announced at the AACR 2026 Annual Meeting, this collaboration
offers a streamlined process from tissue acquisition to metabolic profiling using Panome's TissueBridge™ platform. Audubon Bioscience contributes its extensive biobanking infrastructure, ensuring ethical sourcing and quality control. This partnership aims to facilitate biomarker discovery and drug target identification, leveraging archived clinical samples.
Why It's Important?
The partnership addresses a critical bottleneck in cancer research by enabling access to archived FFPE tissues for metabolomics analysis. This integration of resources and expertise enhances the potential for breakthroughs in cancer diagnostics and treatment. By providing a reliable pathway for researchers, the collaboration could accelerate the development of new therapies and improve patient outcomes. The initiative reflects a growing trend towards multi-omics approaches in biomedical research, highlighting the importance of collaboration in advancing scientific discovery.
What's Next?
Researchers can engage with Panome Bio and Audubon Bioscience at the AACR Annual Meeting to explore the capabilities of the TissueBridge™ platform. The partnership is expected to drive further innovations in cancer research, potentially leading to new collaborations and funding opportunities. As the demand for comprehensive multi-omics solutions grows, similar partnerships may emerge, fostering a more integrated research ecosystem.
